Sample Report | Order Information
| Period ending date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Number of months in period | 12 | 12 | 12 | 12 | 12 |
| Cost report status | As Submitted | As Submitted | Settled Without Audit | Settled Without Audit | Settled With Audit |
| EBITDAR - Earnings Before Interest, Taxes, Depreciation, Amortization, and Rent | $335,621,996 | $322,449,195 | $174,872,173 | $174,883,829 | $412,265,192 |
| Definition: net income + interest + depreciation and amortization + lease cost | |||||
| net income (before taxes) | $234,207,713 | $225,304,442 | $79,825,219 | $80,098,760 | $325,067,409 |
| interest expense | $0 | $0 | $0 | $0 | $0 |
| depreciation and amortization expense | $88,822,525 | $88,491,812 | $91,744,118 | $87,327,032 | $81,884,594 |
| lease cost | $12,591,758 | $8,652,941 | $3,302,836 | $7,458,037 | $5,313,189 |
| Operating Margin | 6.2% | 6.7% | 2.5% | 2.0% | 11.2% |
| Definition: (tot oper rev - tot oper exp) / tot oper rev * 100 | |||||
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| total operating expense | $3,418,363,790 | $3,091,181,946 | $2,909,471,042 | $2,538,763,074 | $2,201,548,096 |
| Excess Margin | 6.4% | 6.8% | 2.7% | 3.1% | 12.9% |
| Definition: (tot oper rev - tot oper exp + non-oper rev) / (tot oper rev + non-oper rev) * 100 | |||||
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| total operating expense | $3,418,363,790 | $3,091,181,946 | $2,909,471,042 | $2,538,763,074 | $2,201,548,096 |
| non-operating revenue (non-patient revenue) | $6,449,115 | $3,258,875 | $4,057,509 | $29,082,344 | $47,140,642 |
| Personnel Expense as a percent of Total Operating Revenue | 26.4% | 28.2% | 30.5% | 32.1% | 24.8% |
| Definition: (salary expense + contract labor + fringe benefits ) / total operating rev * 100 | |||||
| salary expense | $867,409,761 | $841,770,369 | $812,165,153 | $700,673,572 | $615,268,584 |
| contract labor | $93,767,849 | $90,979,301 | $99,151,305 | $130,058,789 | $0 |
| fringe benefits | $45,531 | $40,593 | $135,789 | $55,110 | $33,313 |
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| Return on Equity | 4.7% | 5.1% | 2.1% | 2.3% | 10.1% |
| Definition: net income / (total assets - total liabilities) * 100 | |||||
| net income (before taxes) | $234,207,713 | $225,304,442 | $79,825,219 | $80,098,760 | $325,067,409 |
| total assets (general fund only) | $5,232,894,580 | $4,454,519,225 | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 |
| total liabilities (general fund only) | $198,141,880 | $68,709,060 | $-7,957,731 | $142,105,323 | $251,944,136 |
| Return on Assets (ROA) | 4.5% | 5.1% | 2.1% | 2.2% | 9.4% |
| Definition: net income / total assets * 100 | |||||
| net income (before taxes) | $234,207,713 | $225,304,442 | $79,825,219 | $80,098,760 | $325,067,409 |
| total assets (general fund only) | $5,232,894,580 | $4,454,519,225 | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 |
| Current Ratio | 2.5 | 6.2 | -51.1 | 2.4 | 1.3 |
| Definition: total current assets / total current liabilities | |||||
| total current assets (general fund only) | $498,027,417 | $425,985,037 | $406,625,038 | $340,263,112 | $335,302,065 |
| total current liabilities (general fund only) | $198,141,880 | $68,709,060 | $-7,957,731 | $142,105,323 | $251,944,136 |
| Quick Ratio | 2.1 | 5.1 | -42.8 | 1.9 | 1.1 |
| Definition: (total current assets - inventory) / total current liabilities | |||||
| total current assets (general fund only) | $498,027,417 | $425,985,037 | $406,625,038 | $340,263,112 | $335,302,065 |
| inventory (general fund only) | $78,246,185 | $73,058,722 | $66,021,642 | $68,934,055 | $69,170,691 |
| total current liabilities (general fund only) | $198,141,880 | $68,709,060 | $-7,957,731 | $142,105,323 | $251,944,136 |
| Days Cash on Hand | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Definition: (cash on hand + market securities) / [(total operating expenses - depreciation ) / 365] | |||||
| cash on hand (general fund only) | $9,788 | $7,800 | $8,015 | $8,300 | $11,339 |
| market securities (temporary investments) (general fund only) | $0 | $0 | $0 | $0 | $0 |
| total operating expense | $3,418,363,790 | $3,091,181,946 | $2,909,471,042 | $2,538,763,074 | $2,201,548,096 |
| depreciation expense | $88,822,525 | $88,491,812 | $91,744,118 | $87,327,032 | $81,884,594 |
| Days Cash on Hand - All Sources | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Definition: (cash on hand + mkt securities + investments) / [(total operatingexp - depreciation exp) / 365] | |||||
| cash on hand (general fund only) | $9,788 | $7,800 | $8,015 | $8,300 | $11,339 |
| market securities (temporary investments) (general fund only) | $0 | $0 | $0 | $0 | $0 |
| investments (general fund only) | $0 | $0 | $0 | $0 | $0 |
| total operating expense | $3,418,363,790 | $3,091,181,946 | $2,909,471,042 | $2,538,763,074 | $2,201,548,096 |
| depreciation expense | $88,822,525 | $88,491,812 | $91,744,118 | $87,327,032 | $81,884,594 |
| Days in Net Patient Accounts Receivable | 41.3 | 38.2 | 41.1 | 37.7 | 38.4 |
| Definition: (accounts receivable - allowances for uncollectible) / (total operating revenue / 365) | |||||
| accounts receivable (general fund only) | $412,119,845 | $346,490,150 | $1,726,418,440 | $1,270,291,439 | $1,265,481,897 |
| allowances for uncollectible (general fund only) | $0 | $0 | $1,390,139,525 | $1,002,627,912 | $1,004,863,367 |
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| Days in Net Total Receivable | 41.4 | 38.3 | 41.2 | 37.8 | 38.7 |
| Definition: (accounts receivable + notes receivable + other receivables - allowances for uncollectible) / (total operating revenue / 365) | |||||
| accounts receivable (general fund only) | $412,119,845 | $346,490,150 | $1,726,418,440 | $1,270,291,439 | $1,265,481,897 |
| notes receivable (general fund only) | $0 | $0 | $0 | $0 | $0 |
| other receivables (general fund only) | $1,251,410 | $1,178,246 | $643,322 | $622,153 | $2,046,512 |
| allowances for uncollectible (general fund only) | $0 | $0 | $1,390,139,525 | $1,002,627,912 | $1,004,863,367 |
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| Average Payment Period (days) | 21.7 | 8.4 | -1.0 | 21.2 | 43.4 |
| Definition: total current liabilities / [(total operating expenses + total other expenses - depreciation) / 365] | |||||
| total current liabilities (general fund only) | $198,141,880 | $68,709,060 | $-7,957,731 | $142,105,323 | $251,944,136 |
| total operating expense | $3,418,363,790 | $3,091,181,946 | $2,909,471,042 | $2,538,763,074 | $2,201,548,096 |
| total other expense | $0 | $0 | $0 | $0 | $0 |
| depreciation expense | $88,822,525 | $88,491,812 | $91,744,118 | $87,327,032 | $81,884,594 |
| Inventory Turnover | 46.7 | 45.4 | 45.3 | 38.0 | 36.5 |
| Definition: (total operating revenue + non-operating revenue) / inventory | |||||
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| non-operating revenue (non-patient revenue) | $6,449,115 | $3,258,875 | $4,057,509 | $29,082,344 | $47,140,642 |
| inventory (general fund only) | $78,246,185 | $73,058,722 | $66,021,642 | $68,934,055 | $69,170,691 |
| Total Asset Turnover | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 |
| Definition: (total operating revenue + non-operating revenue) / total assets | |||||
| total operating revenue (net patient revenue) | $3,646,122,388 | $3,313,227,513 | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 |
| non-operating revenue (non-patient revenue) | $6,449,115 | $3,258,875 | $4,057,509 | $29,082,344 | $47,140,642 |
| total assets (general fund only) | $5,232,894,580 | $4,454,519,225 | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 |
| Long Term Debt to Net Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Definition: total long term liabilities / (total assets - total liabilities) | |||||
| total long term liabilities (general fund only) | $0 | $0 | $0 | $0 | $0 |
| total assets (general fund only) | $5,232,894,580 | $4,454,519,225 | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 |
| total liabilities (general fund only) | $198,141,880 | $68,709,060 | $-7,957,731 | $142,105,323 | $251,944,136 |
| Total Debt to Net Assets | 0.04 | 0.02 | 0.00 | 0.04 | 0.08 |
| Definition: total liabilities / (total assets - total liabilities) | |||||
| total assets (general fund only) | $5,232,894,580 | $4,454,519,225 | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 |
| total liabilities (general fund only) | $198,141,880 | $68,709,060 | $-7,957,731 | $142,105,323 | $251,944,136 |
| Average Age of Plant | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Definition: accumulated depreciation / depreciation expense | |||||
| accumulated depreciation | $0 | $0 | $0 | $0 | $0 |
| depreciation expense | $88,822,525 | $88,491,812 | $91,744,118 | $87,327,032 | $81,884,594 |